Drugs / Ashwagandha
Ashwagandha
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT05610735 | Sep 2024 → Nov 2027 expected | ovarian cancer | Sham Sunder Kakar | Recruiting | No outcome recorded |
| Phase 1/2 | NCT03533972 | Nov 2017 → Feb 2018 | chronic periodontitis | Tatyasaheb Kore Dental College | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07575516 | Oct 2025 → Jan 2026 | schizophrenia | Hasanuddin University | Completed | No outcome recorded |
| Phase 2 | NCT04092647 | Jan 2023 → Dec 2024 | chemotherapy-induced toxicity | Sutter Health | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06889584 | Feb → Dec 2025 | — | University of South Carolina | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ashwagandha | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05610735 ↗ |
| Known as | Indian ginseng | “Ashwagandha is also known as Indian ginseng and winter cherry.” NCT03533972 ↗ |
| Known as | winter cherry | “Ashwagandha is also known as Indian ginseng and winter cherry.” NCT03533972 ↗ |
| Known as | Withania somnifera | “Withania somnifera (WS), commonly known as ashwagandha” PMID 41685666 ↗ Feb 2026 |
| Modality | Traditional medicine (herbal / TCM) | “used in the traditional medical system of India” PMID 41685666 ↗ Feb 2026 |
| Route | Oral | “Ashwagandha capsules 500 mg twice daily, after meals with plain water” NCT03533972 ↗ |